Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Tenon Medical (TNON) Amortization of Deferred Charges (2021 - 2022)

Tenon Medical has reported Amortization of Deferred Charges over the past 2 years, most recently at $88000.0 for Q2 2022.

For Q2 2022, Amortization of Deferred Charges rose 44.26% year-over-year to $88000.0; the TTM value through Mar 2023 reached $88000.0, down 90.03%, while the annual FY2022 figure was $362000.0, 41.61% down from the prior year.
Amortization of Deferred Charges for Q2 2022 was $88000.0 at Tenon Medical, down from $274000.0 in the prior quarter.
Over five years, Amortization of Deferred Charges peaked at $280000.0 in Q4 2021 and troughed at $11000.0 in Q1 2021.